explainx.ai350K+ learn from us
TrendingAI News TodayExplainx for Business
Pricing
explainx.ai

Upskill in AI — 16 free pathways, live workshops & bootcamps, and 50+ courses from practitioners. Plus the skills, tools, and MCP servers to practice on.

follow us

follow on google

Add explainx.ai as a preferred source

corporate training

support@explainx.ai

get started

Find your pathTake Free Evaluation

community

Join the community

learn

mind: share how you thinkpathways — start freeworkshopsbootcampscoursescompare Explainxcertificationsmock testsexplainx universitycorporate traininglearn skills & mcp

discover

skillsmcp serversexplainx mcpestacktoolsmdx readeragentsllmsdesignsdictionarypeopleagi trackerfelony benchranks

company

aboutvisionmissionteaminstructorsteach on explainxpartnershipscommunityhackathonscareers

content

daily AI newsstate of AI — live resultsblogreleasespromptsgeneratorsresource libraryfor LLMsexplainx.ai kids

solutions

all solutionsdeveloper upskillingmarketing upskillingproduct manager upskillingleadership upskilling

newsletter · weekly

Get AI news, tools, and insights in your inbox.

supportcontactprivacytermsdata rightshow we create contentsubmission guidelines

© 2026 AISOLO Technologies Pvt Ltd

explainx.ai

On this page

  • TL;DR: scores OpenAI reports at xhigh reasoning
  • What MedChemBench measures
  • Why drug properties trade off
  • Structure reconstruction is the gate
  • Component breakdown and token scaling
  • What MedChemBench is not
  • How builders can use the benchmark
  • Links to OpenAI''s wider November science push
  • Evaluation hygiene checklist
  • National-policy and safety context
  • Walkthrough: how a single problem is framed
  • Token spend versus accuracy
  • Comparison to adjacent public benchmarks
  • Responsible communications for startups
  • Classroom and workshop uses
  • Future updates OpenAI teases
  • Procurement questions for vendor bake-offs
  • Safety and export-control awareness
  • Paper and reproducibility path
  • Integration with cheminformatics stacks
  • Educator and workshop notes
  • Related reading
← Back to blog

explainx / blog

OpenAI MedChemBench: Medicinal Chemistry Tasks, Scores and Limits

OpenAI, MedChemBench, AI for Science, Drug Discovery, Benchmarks

Part of OpenAI and ChatGPT

OpenAI launched MedChemBench on Nov 20, 2026 with 99 medicinal chemistry problems. GPT-6.2 Astra hit 84.5% credit; structures beat compound selection.

Nov 20, 2026·8 min read·Yash Thakker
add explainx.ai
go deep
OpenAI MedChemBench: Medicinal Chemistry Tasks, Scores and Limits

OpenAI asks whether frontier language models can do medicinal chemistry reasoning, not just caption molecules. On November 20, 2026 it announced MedChemBench — 99 graded problems built from published programs where improving one drug property often worsens another.

Daily briefFrom Yash · 350K+ students taught

Catch up on AI

One AI story explained in plain English, plus one thing to try. Every day, free. Unsubscribe anytime.

The release sits beside adversarial distillation safeguards and internal research acceleration metrics as OpenAI tries to show where automation helps science and where it still hallucinates structures.

TL;DR: scores OpenAI reports at xhigh reasoning

table · 4 cols
Model (xhigh)Overall credit (99 problems)OpenAI-highlighted strengthWeak slice
GPT-6.2 Astra84.5%Structure plus evidence explanationSelection and numeric prediction
GPT-6 Astra83.3%95.4% structure component creditAbout half credit on selection and prediction
GPT-6.1 Sol82.0%Competitive overallIllustrated ring failures in legacy tiers
GPT-5.6 Sol58.2%Lagging frontier by OpenAI tableFailed 18-atom ring reconstruction in demo

Higher reasoning settings generally raise scores in OpenAI''s plots, but large gaps between models remain.

What MedChemBench measures

Molecule nodes with one highlighted atom, suggesting structure-first gradingMolecule nodes with one highlighted atom, suggesting structure-first grading

OpenAI groups each problem into four scored components:

  1. Molecular structures — correct atom connectivity and stereochemistry from drawings and specified groups.
  2. Scientific reasoning — explanations tied to supplied experimental evidence.
  3. Ranking and selection — ordering or choosing compounds that meet stated goals.
  4. Property predictions — numeric and categorical agreement with withheld or quoted measurements.

Problems snapshot a point in a medicinal chemistry campaign: target biology, program goals, compounds tested so far, and selected experimental readouts. That mimics how medchem teams decide what to synthesize next, not how Twitter demos caption a SMILES string.

The suite draws on 117 sources and 761 structures, so overlap with training corpora is plausible. OpenAI explicitly flags prior exposure as unruled-out.

Why drug properties trade off

Medicinal chemists routinely fight multi-objective tension. A potent kinase hit may absorb poorly or clear too fast in liver microsomes. Models that optimize one headline metric without the others mislead executive readouts.

OpenAI''s PRMT5 inhibitor vignette shows compound 23 blocking PRMT5 at lower cellular concentration while 24 shows better permeability and slower hepatic breakdown in withheld assays. Models must connect structure edits to competing readouts, the same jagged pattern OpenAI documents for coding agents.

Structure reconstruction is the gate

Folded protein ribbon hinting at spatial chemistry reasoningFolded protein ribbon hinting at spatial chemistry reasoning

Before property talk, the model must assemble the right molecule. One task preserves an 18-atom ring while attaching two groups. OpenAI reports GPT-6 Astra reconstructed it correctly in 10 of 10 xhigh attempts, while GPT-5.6 Sol shrank the ring to 15 atoms and GPT-5.6 Luna split disconnected fragments.

Those errors are not cosmetic. Wrong graphs send every downstream potency prediction off-cliff. Teams evaluating vision-language chemistry tools should treat graph validity as a hard gate, similar to unit tests before merge.

Component breakdown and token scaling

OpenAI plots overall credit versus output tokens across 51 model-and-setting combinations from GPT-5.6 onward, with 95% uncertainty intervals. A companion chart separates component curves, showing structure and explanation rising faster than selection and measurement prediction.

That shape suggests RL-friendly verifiable subtasks (did you draw the graph?) may saturate before judgment-heavy portfolio picks. It rhymes with external METR judgment-task gaps reported the same day, though MedChemBench tasks remain algorithmically scored.

What MedChemBench is not

OpenAI''s limitations section is explicit:

  • No claim that models invent approved drugs
  • No multi-turn lab agent with instruments
  • No guarantee that high benchmark credit changes portfolio decisions

Compare to DOE Genesis open science models or Anthropic''s Genesis Mission credits: government programs fund access, while MedChemBench funds measurement.

How builders can use the benchmark

Pharma ML teams can treat MedChemBench as a regression suite when swapping tokenizers or vision encoders. Failures on ring size or stereochemistry should block deployment even if aggregate accuracy looks flat.

Model hosts should publish per-component dashboards, not one leaderboard number. OpenAI''s component split shows selection remains the business-risk slice.

Educators can use PRMT5-style tradeoff prompts to teach why AI-for-science hype needs assay context.

Links to OpenAI''s wider November science push

The same week OpenAI posted chip design with AI models and continues Rosalind trusted-access tiers for high-risk biology. MedChemBench is the public, published-data lane — lower governance friction, but also lower proof of wet-lab impact.

Evaluation hygiene checklist

table · 2 cols
StepWhy it matters
Freeze reasoning effort settingsOpenAI compares models at shared xhigh labels
Log SMILES and graph editsDetect silent structure drift between turns
Hold out entire paper seriesMedChemBench problems cluster by publication
Run human medchem review on failuresModels may sound plausible while wrong on units
Do not conflate credit with ROIPartial credit masks dangerous tail errors

National-policy and safety context

Drug-discovery assistance sits in the same policy perimeter as cyber and bio distillation fights. OpenAI''s November distillation post notes cyber capabilities migrating to students. Chemistry reasoning could follow similar paths if traces leak from allowed programs.

Labs publishing open weights should pair capability posts with usage monitors, echoing OpenAI frontier risk training controls.

Walkthrough: how a single problem is framed

OpenAI''s post walks through compound 17, where models assemble a large ring system from a central scaffold plus substituents. The grading function is unforgiving: a wrong ring size changes inchi keys and every downstream QSAR-style guess.

That design mirrors how medchem teams actually work in discovery:

  • Medicinal chemists propose analogs from SAR tables in papers.
  • Computational chemists sanity-check graphs before docking or MD.
  • Program leaders ask for explicit tradeoff language, not a single IC50 boast.

MedChemBench forces models to do all three rhetoric layers in text, even though it does not run robots or mass spec.

Token spend versus accuracy

OpenAI''s Figure 2 plots overall credit against tokens, including reasoning tokens. Scores rise with compute, but marginal gains shrink on selection tasks. Teams budgeting API spend for science assistants should expect nonlinear bills: the last 5 percentage points may cost more tokens than the first twenty.

Compare with OpenAI''s $2,400 median daily agent spend figure for coding researchers — chemistry benches may show similar heavy-tail spend if users crank reasoning effort to max on every compound panel.

Comparison to adjacent public benchmarks

MedChemBench is narrower than general science Q&A sets but deeper per compound than many SMILES-only leaderboards. It complements:

  • Physics and math formal benchmarks OpenAI discussed in Yang-Mills Lean work
  • Chip design tasks in OpenAI''s November 18 silicon post
  • Enterprise chemistry copilots vendors sell without publishing task definitions

Without public task JSON, external labs cannot reproduce scores exactly. OpenAI''s paper link is the reproducibility anchor.

Responsible communications for startups

If your pitch deck says MedChemBench proves AI drug discovery, you are ahead of OpenAI''s own disclaimer. Safer claims:

  • Models parse structures from literature-style prompts at high rates on this suite
  • Models still miss portfolio judgments that humans make with incomplete assays
  • Benchmark credit is partial; tail failures can be toxicology-relevant

Regulators and partners will ask for wet-lab confirmatory data, not LLM percentages.

Classroom and workshop uses

Instructors can assign students to:

  1. Reconstruct compound 17 by hand from the same prompt text
  2. Compare human SAR narrative to model narrative
  3. Identify where partial credit would hide a fatal graph error

That pedagogy aligns with explainx.ai workshop style: verify graphs before trusting prose.

Future updates OpenAI teases

The November post closes by saying MedChemBench should support continued progress as models advance. Watch for:

  • New reasoning tiers on GPT-6.x lines
  • Additional component weighting if selection improves
  • Possible tool-using extensions (not in v1 scoring)

We will update this page if OpenAI ships a revision with new task counts or public leaderboards.

Procurement questions for vendor bake-offs

Enterprise buyers evaluating chemistry copilots should ask vendors for MedChemBench component splits, not a marketing screenshot. Request:

  • Raw JSONL outputs on a holdout subset they did not train on
  • Error taxonomy on graph failures versus unit failures
  • Whether vision inputs match OpenAI''s drawing format or proprietary sketches

If a vendor refuses, treat headline accuracy as unaudited.

Safety and export-control awareness

Medicinal chemistry assistance can touch controlled precursor knowledge depending on jurisdiction. OpenAI places this release in the research transparency bucket, not a weapons-design claim. Still, infosec teams should log which employees run long chemistry chains on frontier APIs, similar to cyber dual-use policies in OpenAI distillation safeguards.

Paper and reproducibility path

OpenAI''s announcement links Read the paper from the same page. Teams reproducing scores should download that PDF for exact rubric weights, partial-credit formulas, and any holdout splits. Without the paper hash pinned in your MLOps repo, you cannot defend a vendor bake-off outcome six months later.

Document:

  • Model ID and reasoning-effort knob per attempt
  • Temperature and seed if exposed
  • Prompt hash for each of the 99 tasks once JSON releases

Integration with cheminformatics stacks

Most builders will not call ChatGPT for every analog. They will pipe RDKit, OpenBabel, or enterprise ELN exports into an API. MedChemBench instead tests literature reasoning, closer to how a medicinal chemist reads a patent table than how a docking pipeline scores poses.

That gap means high MedChemBench credit does not imply high docking RMSD or MD stability. Use the benchmark where it measures narrative SAR quality, not physics engines.

Educator and workshop notes

Workshop facilitators can run a blind review: students grade model paragraphs before seeing model IDs. Disagreement between human medchem TAs and model scores illustrates judgment-heavy evaluation — the same theme METR highlighted on AI R&D tasks.

Related reading

  • OpenAI adversarial distillation safeguards
  • OpenAI research acceleration jagged frontier
  • METR time horizon judgment tasks
  • DOE Genesis open models program
  • Anthropic Genesis Mission credits
  • Google AI in science jagged frontier
  • Open OCR and document pipelines for chemistry PDFs
Spotted something out of date? Let us know.
Daily briefFrom Yash · 350K+ students taught

Catch up on AI

One AI story explained in plain English, plus one thing to try. Every day, free. Unsubscribe anytime.

  • ✓ Free
  • ✓ One email a day, no spam
  • ✓ Unsubscribe anytime
Yash Thakker

Written by

Yash Thakker

Yash is an AI expert with over 300K learners. Join his workshops →

View Yash Thakker in People in AI →

Related posts

Oct 22, 2026

Warp Sciences: Kevin Weil's Plan to Train Robots to Run Drug-Discovery Wet Labs

Former OpenAI science lead Kevin Weil has launched Warp Sciences, a startup that wants human chemists, wearing cameras and sensor gloves, to train robots to synthesize and test drug candidates around the clock. The pitch is automation of wet-lab work now outsourced to contractors in China. Here is what has been reported, what the data strategy is, and what remains to be shown.

Nov 18, 2026

GPT-6.2 Astra and Sol: Why Benchmarks and Power-User Reviews Diverge

On November 17, 2026 OpenAI shipped GPT-6.2 Astra and Sol with higher scores and a 20% Astra API cut. Within hours, early testers including Matt Shumer and Theo Browne posted harsh reviews beside fans who praise 3D and VFX work. This post maps what is measured versus what builders feel on long jobs.

Nov 17, 2026

GPT-6.2 Astra vs Sol vs Claude Fable 5.2 vs Gemini 4 Argon (November 2026)

OpenAI shipped GPT-6.2 on November 17, 2026. This comparison lines up 6.2 Astra and Sol against Claude Fable 5.2 and Gemini 4 Argon on list price, Agents Last Exam, FrontierCode 2.0, Terminal-Bench-Science, and cyber tiers.